Figures & data
Table I. Incidence of CTCAEv3 grade 3 acute dysphagia (treatment weeks 1–6 /7*) in ALL patients compared to Definitive and PORT.
Table II. Incidence of CTCAEv3 grade 3 acute dysphagia (treatment weeks 1–6 /7*) in ALL patients compared to CRT and RT Only.
Table III. Dosimetric and clinical risk factors affecting incidence of CTCAEv3 Grade 3 acute dysphagia (Total Grade 3 patients, N = 47).